Tag Archives: resistance

Resistance Strikes Will Increase in Coming Days – Abu Obeida’s Speech on the 100th Day of War – Palestine Chronicle

  1. Resistance Strikes Will Increase in Coming Days – Abu Obeida’s Speech on the 100th Day of War Palestine Chronicle
  2. Abu Obaida Says ‘Crying’ Israeli Soldiers Seen In Gaza As IDF Death Toll Rises; Slams Its Arms Claim Hindustan Times
  3. Lone Hamas Fighter Confronts Israel Army Bulldozer In Gaza | Watch What Happened Next Hindustan Times
  4. Al Quds Sniper ‘Kills’ Israeli Soldier In Khan Younis; IDF Units ‘Bombed’ By Mujahideen Brigades Hindustan Times
  5. Abu Obaida Warns Iran’s ‘Axis Of Resistance Will Expand Attacks’ | ‘1,000 IDF Vehicles Crushed…’ Hindustan Times

Read original article here

How Palestinians are using art as a form of resistance against Israel | The Stream – Al Jazeera English

  1. How Palestinians are using art as a form of resistance against Israel | The Stream Al Jazeera English
  2. Thousands of musicians sign letter for Gaza ceasefire Euronews
  3. “We speak out together in solidarity with the Palestinian people’s struggle for freedom, justice and equal rights”: Rage Against The Machine, Mogwai, Pulp among 4000 artists calling for a ceasefire in Gaza Louder
  4. When artists aren’t allowed to speak about the war in Gaza CBC.ca
  5. Pulp and Lucy Dacus among thousands of musicians to have signed letter for Gaza ceasefire NME
  6. View Full Coverage on Google News

Read original article here

Venezuela tells World Court referendum to go ahead despite Guyana resistance – Reuters Canada

  1. Venezuela tells World Court referendum to go ahead despite Guyana resistance Reuters Canada
  2. At the UN’s top court, Venezuela vows to press ahead with referendum on future of disputed region The Associated Press
  3. THE HAGUE – The International Court of Justice (ICJ) holds public hearings in the case Guyana v. Venezuela – oral argument of Venezuela (Spanish version/version espagnole/versión en español) UN Web TV
  4. Venezuela’s Maduro Wants UN to Intervene in Dispute With Guyana Bloomberg
  5. Guyana tells UN court that Venezuelan referendum on territorial dispute is an ‘existential threat’ The Associated Press
  6. View Full Coverage on Google News

Read original article here

The Interview – Reza Pahlavi, son of Iran’s last shah: A year after Amini’s death ‘a new phase of resistance’ – FRANCE 24 English

  1. The Interview – Reza Pahlavi, son of Iran’s last shah: A year after Amini’s death ‘a new phase of resistance’ FRANCE 24 English
  2. ‘Alien’ remains and a Mahsa Amini protest: Thursday’s best photos The Guardian
  3. Opinion | Life after prison: Iranian women who stood up for Mahsa Amini The Washington Post
  4. Reza Pahlavi, the son of Iran’s last shah: ‘We’re entering a new face of a resistance’ in Iran FRANCE 24 English
  5. A year on, Mahsa Amini’s death exposes divides in Iran establishment Al-Monitor
  6. View Full Coverage on Google News

Read original article here

Futures: Can Bulls Break Above Resistance? 10 Stocks To Watch – Investor’s Business Daily

  1. Futures: Can Bulls Break Above Resistance? 10 Stocks To Watch Investor’s Business Daily
  2. Nvidia And This AI Stock Lead 5 Names Near Buy Points Investor’s Business Daily
  3. Growth Stocks: Four IBD 50 Stocks Are At Risk, With One Already Dropping Off | Investor’s Business Daily Investor’s Business Daily
  4. AAON Stock, American Airlines, Arch Capital And 8 Others Enter IBD Stock Watchlists Investor’s Business Daily
  5. Dow Jones Futures: Can Bulls Break Above Resistance? Nvidia Leads 10 Stocks Near Buy Points | Investor’s Business Daily Investor’s Business Daily
  6. View Full Coverage on Google News

Read original article here

Bitcoin barely holds $28K as bulls see new rejection at key resistance – Cointelegraph

  1. Bitcoin barely holds $28K as bulls see new rejection at key resistance Cointelegraph
  2. Analyst Who Perfectly Called Bitcoin Boom Issues Major Update to Crypto Traders The Daily Hodl
  3. Top 3 Price Prediction Bitcoin, Ethereum, Ripple: Crypto markets slide lower in search of reaccumulation zones FXStreet
  4. Bitcoin, Ethereum Technical Analysis: BTC Moves Above $28500 as ETH Nears $2000 – Market Updates Bitcoin News Bitcoin News
  5. Top Crypto Strategist Issues Bitcoin Warning, Says Only a Matter of Time Before BTC Witnesses Deep Correction The Daily Hodl
  6. View Full Coverage on Google News

Read original article here

Special prosecutor for St. Louis faces resistance in Missouri Senate hearing – St. Louis Post-Dispatch

  1. Special prosecutor for St. Louis faces resistance in Missouri Senate hearing St. Louis Post-Dispatch
  2. St. Louis prosecutor faces mounting criticism over crash Yahoo News
  3. Judge gives St. Louis Circuit Attorney Kim Gardner 14 days to respond to removal petition KSDK.com
  4. Far-left prosecutor slammed for incompetence after repeat offender critically injures teen volleyball player Fox News
  5. Missouri prosecutors decry bill to supplant Kim Gardner as St. Louis circuit attorney • Missouri Independent Missouri Independent
  6. View Full Coverage on Google News

Read original article here

Antibiotic resistance induced by the widespread use of… antidepressants?

Jianhua Guo is a professor at the Australian Centre for Water and Environmental Biotechnology. His research focuses on removing contaminants from wastewater and the environmental dimensions of antimicrobial resistance. One of those dimensions is the overuse of antibiotics, which promotes resistance to these drugs.

Guo wondered if the same might hold true for other types of pharmaceuticals as well. His lab found that they definitely do. Specific antidepressants—SSRIs and SNRIs—promote resistance to different classes of antibiotics. This resistance is heritable over 33 bacterial generations, even once the antidepressant is removed.

So much work

Antidepressants are among the most prescribed and ingested drugs there are. They account for roughly 5 percent of the pharmaceutical market share—about the same as antibiotics—and four of the top 10 most prescribed psychiatric meds in the US.

To assess antidepressants’ potential effects on antibiotic resistance, Guo’s lab grew E. coli in the presence of physiologically relevant concentrations of five commonly prescribed antidepressants for 60 days and measured how well the bacteria grew on agar plates infused with different antibiotics. They looked at antibiotics with different mechanisms of action: some that worked by inhibiting DNA synthesis in the bacteria, others that worked by inhibiting protein synthesis, and others by inhibiting cell wall synthesis. They found that the antidepressants they tested induced resistance to multiple antibiotics—within a day.

This group did a ton of experiments to try to determine how this was happening, starting by sequencing the DNA, mRNA, and proteins of the antibiotic-resistant bacteria. They saw that the antidepressants caused the bacteria to produce reactive oxygen species, which can damage cellular components. This seemed to be essential for the evolution of antibiotic resistance, as the resistance didn’t arise when cells were grown without oxygen. The drugs also caused the bacteria to express more efflux pump proteins that shunt antibiotics out of the cell. Genetic mutations in the bacterial chromosomes that promoted multi-drug resistance were also more common.

The scientists then looked at time-lapse microscopy images of DNA moving between bacterial cells, a process that can enable the rapid spread of resistance genes. Guess what? The SSRI sped it up and increased its occurrence, allowing resistant bacteria to spread the resistance horizontally to their peers (in addition to vertically to their progeny).

Persistence can lead to resistance

The antidepressants also increased the percentage of bacterial cells that persist in the presence of high concentrations of antibiotics. These “persisters” aren’t quite antibiotic resistant, exactly—they have none of the genetic mutations that confer antibiotic resistance. They are still normal bacteria; they just randomly have a higher tolerance for antibiotics than their peers. The researchers generated a mathematical model of bacterial evolution, which suggests that antidepressants increase the rate at which both normal bacteria and persisters evolve into full-fledged multi-drug-resistant strains.

Antibiotic resistance is an enormous threat to human health. Since antidepressants are prescribed and used in such massive quantities, the fact that they can induce antibiotic resistance should not be considered one of the more trivial of their side effects. It might even be taken into account in the design of new, more effective antidepressants.

PNAS, 2023. DOI: 10.1073/pnas.2208344120

Read original article here

Dow Jones Futures Due: Market Rally Clears Resistance; Tesla’s Big Transition

Dow Jones futures will open Sunday evening, along with S&P 500 futures and Nasdaq futures.




X



The stock market rally picked up steam in the past week, with strong gains, clearing key levels. The S&P 500 briefly faced resistance at the 200-day line, but moved above that key level on Friday. A large number of leading stocks flashed buy points.

Investors can be adding exposure gradually as the market rally improves. While many top stocks are now extended, Wendy’s (WEN), Exxon Mobil (XOM), Quanta Services (PWR), Celsius Holdings (CELH) and Insulet (PODD) are all actionable from early entries. Wendy’s and PWR stock have new flat bases, joining XOM stock and Insulet. CELH stock needs another week to forge a proper base.

CELH stock is on SwingTrader and the IBD 50. Celsius, Insulet and Wendy’s were the most recent three IBD Stock Of The Day selections.

Meanwhile, Tesla (TSLA) on Friday announced big price cuts in the U.S. and Europe, a week after slashing prices in China and key Asian markets.

Tesla stock closed modestly lower but rebounded solidly for the week. But the EV giant faces a painful transition as investors increasingly view Tesla as an automaker, not a tech company.

The video embedded in this article discussed the strong week for the market rally, and analyzed WEN stock, Quanta Services and Celsius.

Bitcoin Price

The Bitcoin price briefly topped $21,200 Friday night, a two-month high. The leading cryptocurrency is currently trading around $20,800. Bitcoin was trading just below $17,000 as recently as Jan. 8.

Bitcoin’s rise coincides with the stock market rally, which is showing a return to more speculative investments. That includes growth stocks, especially speculative-type plays like the ARKK ETF. Some meme stocks had a big week, notably Bed Bath & Beyond (BBBY). BBBY stock skyrocketed 179%, even though the retailer has signaled it’s heading toward bankruptcy.

Dow Jones Futures Today

Dow Jones futures open at 6 p.m. ET, along with S&P 500 futures and Nasdaq 100 futures.

U.S. stock and bond markets will be closed Monday for the Martin Luther King Jr. holiday, but other exchanges around the world will be open.

Remember that overnight action in Dow futures and elsewhere doesn’t necessarily translate into actual trading in the next regular stock market session.


Join IBD experts as they analyze actionable stocks in the stock market rally on IBD Live


Stock Market Rally

The stock market rally had a strong week, with the major indexes closing near session highs.

The Dow Jones Industrial Average rose 2% in last week’s stock market trading. The S&P 500 index popped 2.7%. The Nasdaq composite leapt 4.8%. The small-cap Russell 2000 jumped 5.3%.

The 10-year Treasury yield fell 6 basis points to 3.51%, even with Friday’s bounce. Markets strongly expect quarter-point Fed rate hikes in February and March, but then see policymakers on hold. Falling Treasury yields and brighter economic prospects elsewhere are pressuring the dollar, providing another boost to stocks and commodities.

U.S. crude oil futures jumped 8.3% to $79.86 a barrel last week. Copper prices jumped 7.65%.

ETFs

Among growth ETFs, the Innovator IBD 50 ETF (FFTY) rallied 4.4% last week, while the Innovator IBD Breakout Opportunities ETF (BOUT) climbed 2.1%. The iShares Expanded Tech-Software Sector ETF (IGV) leapt 4.9%. The VanEck Vectors Semiconductor ETF (SMH) soared 6.7%.

Reflecting more-speculative story stocks, ARK Innovation ETF (ARKK) spiked 14.7% last week and ARK Genomics ETF (ARKG) just over 16%. TSLA stock is a major holding across Ark Invest’s ETFs. Cathie Wood’s Ark has restocked its Tesla holdings in recent days and weeks.

SPDR S&P Metals & Mining ETF (XME) bounced 6.3% last week to a seven-month high. The Global X U.S. Infrastructure Development ETF (PAVE) rolled 4.2% higher. U.S. Global Jets ETF (JETS) ascended 9.4%. SPDR S&P Homebuilders ETF (XHB) gained 4.6%, despite weak KB Home (KBH) earnings. The Energy Select SPDR ETF (XLE) edged up 0.14%, with XOM stock a major component. The Financial Select SPDR ETF (XLF) rose 2.1%. The Health Care Select Sector SPDR Fund (XLV) edged down 0.2%.


Five Best Chinese Stocks To Watch Now


Stocks In Buy Areas

Wendy’s stock staged a big upside reversal Friday, jumping 6% to 23.08 after hitting an intraday low of 21.36. WEN stock regained its 50-day line, moved above the 21-day and broke above a trendline. That offered an early entry in the new flat base. The official buy point is 23.88, according to MarketSmith analysis.

Wendy’s on Friday reported a fourth-straight quarter of accelerating sales growth, doubled its dividend and announced a $500 million buyback.

XOM stock rose 2.4% to 113.16 last week, its fifth straight weekly gain. Shares are slightly below the official 114.76 buy point, and they wouldn’t seem extended from the 50-day line with that move. But investors already could enter Exxon stock.

PWR stock jumped 6.7% to 148.50 last week, rebounding back above the 50-day line, offering an early entry. Shares also reclaimed a prior 144.41 buy point that’s no longer valid.

CELH stock popped Wednesday above the 50-day and 21-day line, breaking a downtrend, offering multiple reasons for an early entry. Shares held support at the 21-day, then peeked higher Friday. Celsius stock is actionable now after soaring 13.2% for the week.

Insulet stock rose 4.65% in the past week to 305.89, rebounding from the 21-day and 50-day lines. Shares are actionable now. But investors could wait for a break of a trendline, currently slightly above Friday’s high of 309.44.

Tesla Stock Downshifts To Auto?

Tesla stock rallied 8.3% to 122.40 last week, continuing a bounce from the Jan. 6 bear market low of 101.81. Shares edged down 0.9% Friday, well off intraday lows despite Tesla announcing sweeping price cuts in the U.S. and Europe. That came a week after Tesla slashed prices in China and key Asian markets.

The price cuts should fuel sales, especially in the U.S., with more Tesla EV variants eligible for a $7,500 tax credit. That means a huge price cut for U.S. consumers. But Tesla’s prized margins are likely to take a hit.

On Tuesday, investors will get weekly China EV registrations, which should show a big jump in Tesla sales, as well as any possible impact on rivals. But will Tesla have a lasting boost, especially in China and Europe? Orders significantly lagged deliveries in late 2022, so Tesla needs a big boost in new demand just to maintain the current delivery pace in 2023.

Already-fierce competition in China will intensify in 2023, with Tesla’s price reductions perhaps triggering a wave of margin-killing cuts. Europe is increasingly crowded, as well. Even the U.S. EV market will be more competitive in a year, with the tumble in used-car prices already a big drag on new-vehicle prices.

But setting aside Tesla’s EV sales, TSLA stock has a bigger problem. Investors increasingly view the EV giant as an automaker, not a tech company. Tesla’s current price-earnings ratio of 33 is not too steep for a tech growth company. But it’s unusually high for an automaker. Auto industry advantages and margins tend to erode relatively quickly, which may be happening to Tesla right now.

TSLA stock may deserve a high valuation for an automaker, reflecting the EV giant’s still-robust EPS and sales growth. But even so, that would suggest a much-lower valuation than it’s boasted up until recently.

General Motors (GM), Ford (F) and Chrysler-and-Fiat parent Stellantis (STLA) all have P-E ratios in the single digits. Toyota (TM) is at 10.


Tesla Vs. BYD: EV Giants Vie For Crown, But Which Is The Better Buy?


Market Rally Analysis

The stock market rally had an encouraging week, building on strong Jan. 6 gains. The major indexes rose solidly, regaining key levels. A large number of leading stocks flashed buy signals during the week, with most holding or extending gains.

The S&P 500 index moved above its 50-day moving average and came up to its 200-day line. The benchmark index hit resistance at that key level on Thursday-Friday, but ultimately powered above it.

The Dow Jones, Russell 2000 and S&P MidCap 400 are above all their moving averages and closing in on their December short-term highs.

The Nasdaq reclaimed its 50-day moving average and moved above the 11,000 level. The laggard index had been close to its bear market lows at the start of the year.

On Friday, stocks opened solidly lower, as earnings initially hit airlines, health insurers and bank stocks, Tesla price cuts slammed auto stocks and an analyst downgrade hit big defense contractors.

Even without the negative headlines, the market arguably was due for a pullback after the strong gains and with the S&P 500 at the 200-day line.

Yet the market quickly bounced back and closed higher.

Industrials, the broad housing sector, many medicals as well as some retailers and restaurants are showing strength.

Tech names are still scarce among leading stocks, though they are trying to come back. The SMH chip ETF cleared its 200-day line this past week, while the IGV software ETF and ARKK are above their 50-day average.

The S&P 500 still needs to decisively clear the 200-day line. The December highs loom large for all the main indexes.

While the stock market appears to be less concerned about the Federal Reserve, with a path toward a rate hike pause, earnings season will take center stage.


Time The Market With IBD’s ETF Market Strategy


What To Do Now

Investors can be making new buys as stocks continue to improve. But do so gradually. While the market rally has shown strength and resilience in recent days, a pullback would not be a surprise for the major indexes, key sectors or individual stocks.

Earnings season will intensify for the next few weeks, creating the potential for major swings. Exxon and Tesla stock will report within the next three weeks, along with tech giants Apple (AAPL), Microsoft (MSFT), Amazon.com (AMZN) and Google parent Alphabet (GOOGL).

So don’t get too concentrated into a particular sector, even if it’s performing well. Strive for a diversity of leading stocks.

Bulk up your watchlists. Look for stocks that are actionable, setting up, or potentially actionable if they pause or pull back. Broad strength, at least outside of tech, should offer a number of opportunities.

Read The Big Picture every day to stay in sync with the market direction and leading stocks and sectors.

Please follow Ed Carson on Twitter at @IBD_ECarson for stock market updates and more.

YOU MIGHT ALSO LIKE:

Why This IBD Tool Simplifies The Search For Top Stocks

Best Growth Stocks To Buy And Watch

IBD Digital: Unlock IBD’s Premium Stock Lists, Tools And Analysis Today

This Hot Sector Boasts A $1 Trillion Government Tailwind



Read original article here

Market Rally Breaks Past Resistance; Tesla’s Painful Transition

The stock market rally picked up steam in the past week, with strong gains, clearing key levels. The S&P 500 briefly faced resistance at the 200-day line, but moved above that key level on Friday. A large number of leading stocks flashed buy points.




X



Dow Jones futures will open Sunday evening, along with S&P 500 futures and Nasdaq futures. Over the weekend, Bitcoin continued its recent rapid ascent.

Investors can be adding exposure gradually as the market rally improves. While many top stocks are now extended, Wendy’s (WEN), Exxon Mobil (XOM), Quanta Services (PWR), Celsius Holdings (CELH) and Insulet (PODD) are all actionable from early entries. Wendy’s and PWR stock have new flat bases, joining XOM stock and Insulet. CELH stock needs another week to forge a proper base.

CELH stock is on SwingTrader and the IBD 50. Celsius, Insulet and Wendy’s were the most recent three IBD Stock Of The Day selections.

Meanwhile, Tesla (TSLA) on Friday announced big price cuts in the U.S. and Europe, a week after slashing prices in China and key Asian markets.

Tesla stock closed modestly lower but rebounded solidly for the week. But the EV giant faces a painful transition as investors increasingly view Tesla as an automaker, not a tech company.

The video embedded in this article discussed the strong week for the market rally, and analyzed WEN stock, Quanta Services and Celsius.

Bitcoin Price

The Bitcoin price briefly topped $21,200 early Saturday. The leading cryptocurrency is currently trading around $20,900, up more than 10% vs. 24 hours earlier. Bitcoin was trading just below $17,000 as recently as Jan. 8.

Bitcoin’s rise coincides with the stock market rally, which is showing a return to more speculative investments. That includes growth stocks, especially speculative-type plays like the ARKK ETF. Some meme stocks had a big week, notably Bed Bath & Beyond (BBBY). BBBY stock skyrocketed 179%, even though the retailer has signaled it’s heading toward bankruptcy.

Dow Jones Futures Today

Dow Jones futures open at 6 p.m. ET on Sunday, along with S&P 500 futures and Nasdaq 100 futures.

U.S. stock and bond markets will be closed Monday for the Martin Luther King Jr. holiday, but other exchanges around the world will be open.

Remember that overnight action in Dow futures and elsewhere doesn’t necessarily translate into actual trading in the next regular stock market session.


Join IBD experts as they analyze actionable stocks in the stock market rally on IBD Live


Stock Market Rally

The stock market rally had a strong week, with the major indexes closing near session highs.

The Dow Jones Industrial Average rose 2% in last week’s stock market trading. The S&P 500 index popped 2.7%. The Nasdaq composite leapt 4.8%. The small-cap Russell 2000 jumped 5.3%.

The 10-year Treasury yield fell 6 basis points to 3.51%, even with Friday’s bounce. Markets strongly expect quarter-point Fed rate hikes in February and March, but then see policymakers on hold. Falling Treasury yields and brighter economic prospects elsewhere are pressuring the dollar, providing another boost to stocks and commodities.

U.S. crude oil futures jumped 8.3% to $79.86 a barrel last week. Copper prices jumped 7.65%.

ETFs

Among growth ETFs, the Innovator IBD 50 ETF (FFTY) rallied 4.4% last week, while the Innovator IBD Breakout Opportunities ETF (BOUT) climbed 2.1%. The iShares Expanded Tech-Software Sector ETF (IGV) leapt 4.9%. The VanEck Vectors Semiconductor ETF (SMH) soared 6.7%.

Reflecting more-speculative story stocks, ARK Innovation ETF (ARKK) spiked 14.7% last week and ARK Genomics ETF (ARKG) just over 16%. TSLA stock is a major holding across Ark Invest’s ETFs. Cathie Wood’s Ark has restocked its Tesla holdings in recent days and weeks.

SPDR S&P Metals & Mining ETF (XME) bounced 6.3% last week to a seven-month high. The Global X U.S. Infrastructure Development ETF (PAVE) rolled 4.2% higher. U.S. Global Jets ETF (JETS) ascended 9.4%. SPDR S&P Homebuilders ETF (XHB) gained 4.6%, despite weak KB Home (KBH) earnings. The Energy Select SPDR ETF (XLE) edged up 0.14%, with XOM stock a major component. The Financial Select SPDR ETF (XLF) rose 2.1%. The Health Care Select Sector SPDR Fund (XLV) edged down 0.2%.


Five Best Chinese Stocks To Watch Now


Stocks In Buy Areas

Wendy’s stock staged a big upside reversal Friday, jumping 6% to 23.08 after hitting an intraday low of 21.36. WEN stock regained its 50-day line, moved above the 21-day and broke above a trendline. That offered an early entry in the new flat base. The official buy point is 23.88, according to MarketSmith analysis.

Wendy’s on Friday reported a fourth-straight quarter of accelerating sales growth, doubled its dividend and announced a $500 million buyback.

XOM stock rose 2.4% to 113.16 last week, its fifth straight weekly gain. Shares are slightly below the official 114.76 buy point, and they wouldn’t seem extended from the 50-day line with that move. But investors already could enter Exxon stock.

PWR stock jumped 6.7% to 148.50 last week, rebounding back above the 50-day line, offering an early entry. Shares also reclaimed a prior 144.41 buy point that’s no longer valid.

CELH stock popped Wednesday above the 50-day and 21-day line, breaking a downtrend, offering multiple reasons for an early entry. Shares held support at the 21-day, then peeked higher Friday. Celsius stock is actionable now after soaring 13.2% for the week.

Insulet stock rose 4.65% in the past week to 305.89, rebounding from the 21-day and 50-day lines. Shares are actionable now. But investors could wait for a break of a trendline, currently slightly above Friday’s high of 309.44.

Tesla Stock Downshifts To Auto?

Tesla stock rallied 8.3% to 122.40 last week, continuing a bounce from the Jan. 6 bear market low of 101.81. Shares edged down 0.9% Friday, well off intraday lows despite Tesla announcing sweeping price cuts in the U.S. and Europe. That came a week after Tesla slashed prices in China and key Asian markets.

The price cuts should fuel sales, especially in the U.S., with more Tesla EV variants eligible for a $7,500 tax credit. That means a huge price cut for U.S. consumers. But Tesla’s prized margins are likely to take a hit.

On Tuesday, investors will get weekly China EV registrations, which should show a big jump in Tesla sales, as well as any possible impact on rivals. But will Tesla have a lasting boost, especially in China and Europe? Orders significantly lagged deliveries in late 2022, so Tesla needs a big boost in new demand just to maintain the current delivery pace in 2023.

Already-fierce competition in China will intensify in 2023, with Tesla’s price reductions perhaps triggering a wave of margin-killing cuts. Europe is increasingly crowded, as well. Even the U.S. EV market will be more competitive in a year, with the tumble in used-car prices already a big drag on new-vehicle prices.

But setting aside Tesla’s EV sales, TSLA stock has a bigger problem. Investors increasingly view the EV giant as an automaker, not a tech company. Tesla’s current price-earnings ratio of 33 is not too steep for a tech growth company. But it’s unusually high for an automaker. Auto industry advantages and margins tend to erode relatively quickly, which may be happening to Tesla right now.

TSLA stock may deserve a high valuation for an automaker, reflecting the EV giant’s still-robust EPS and sales growth. But even so, that would suggest a much-lower valuation than it’s boasted up until recently.

General Motors (GM), Ford (F) and Chrysler-and-Fiat parent Stellantis (STLA) all have P-E ratios in the single digits. Toyota (TM) is at 10.


Tesla Vs. BYD: EV Giants Vie For Crown, But Which Is The Better Buy?


Market Rally Analysis

The stock market rally had an encouraging week, building on strong Jan. 6 gains. The major indexes rose solidly, regaining key levels. A large number of leading stocks flashed buy signals during the week, with most holding or extending gains.

The S&P 500 index moved above its 50-day moving average and came up to its 200-day line. The benchmark index hit resistance at that key level on Thursday-Friday, but ultimately powered above it.

The Dow Jones, Russell 2000 and S&P MidCap 400 are above all their moving averages and closing in on their December short-term highs.

The Nasdaq reclaimed its 50-day moving average and moved above the 11,000 level. The laggard index had been close to its bear market lows at the start of the year.

On Friday, stocks opened solidly lower, as earnings initially hit airlines, health insurers and bank stocks, Tesla price cuts slammed auto stocks and an analyst downgrade hit big defense contractors.

Even without the negative headlines, the market arguably was due for a pullback after the strong gains and with the S&P 500 at the 200-day line.

Yet the market quickly bounced back and closed higher.

Industrials, the broad housing sector, many medicals as well as some retailers and restaurants are showing strength.

Tech names are still scarce among leading stocks, though they are trying to come back. The SMH chip ETF cleared its 200-day line this past week, while the IGV software ETF and ARKK are above their 50-day average.

The S&P 500 still needs to decisively clear the 200-day line. The December highs loom large for all the main indexes.

While the stock market appears to be less concerned about the Federal Reserve, with a path toward a rate hike pause, earnings season will take center stage.


Time The Market With IBD’s ETF Market Strategy


What To Do Now

Investors can be making new buys as stocks continue to improve. But do so gradually. While the market rally has shown strength and resilience in recent days, a pullback would not be a surprise for the major indexes, key sectors or individual stocks.

Earnings season will intensify for the next few weeks, creating the potential for major swings. Exxon and Tesla stock will report within the next three weeks, along with tech giants Apple (AAPL), Microsoft (MSFT), Amazon.com (AMZN) and Google parent Alphabet (GOOGL).

So don’t get too concentrated into a particular sector, even if it’s performing well. Strive for a diversity of leading stocks.

Bulk up your watchlists. Look for stocks that are actionable, setting up, or potentially actionable if they pause or pull back. Broad strength, at least outside of tech, should offer a number of opportunities.

Read The Big Picture every day to stay in sync with the market direction and leading stocks and sectors.

Please follow Ed Carson on Twitter at @IBD_ECarson for stock market updates and more.

YOU MIGHT ALSO LIKE:

Why This IBD Tool Simplifies The Search For Top Stocks

Best Growth Stocks To Buy And Watch

IBD Digital: Unlock IBD’s Premium Stock Lists, Tools And Analysis Today

This Hot Sector Boasts A $1 Trillion Government Tailwind



Read original article here